| Literature DB >> 25427762 |
Regiane R Santos1, Eric J Schoevers, Bernard A J Roelen.
Abstract
Women presenting fertility problems are often helped by Assisted Reproductive Techniques (ART), such as in vitro fertilization (IVF) programs. However, in many cases the etiology of the in/subfertility remains unknown even after treatment. Although several aspects should be considered when assisting a woman with problems to conceive, a survey on the patients' exposure to contaminants would help to understand the cause of the fertility problem, as well as to follow the patient properly during IVF. Daily exposure to toxic compounds, mainly environmental and dietary ones, may result in reproductive impairment. For instance, because affects oocyte developmental competence. Many of these compounds, natural or synthetic, are endocrine disruptors or endocrine active substances that may impair reproduction. To understand the risks and the mechanism of action of such chemicals in human cells, the use of proper in vitro models is essential. The present review proposes the bovine and porcine models to evaluate toxic compounds on oocyte maturation, fertilization and embryo production in vitro. Moreover, we discuss here the species-specific differences when mice, bovine and porcine are used as models for human.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25427762 PMCID: PMC4258035 DOI: 10.1186/1477-7827-12-117
Source DB: PubMed Journal: Reprod Biol Endocrinol ISSN: 1477-7827 Impact factor: 5.211
Figure 1Main differences between murine, porcine, bovine and human oocyte size at maturation, time to maturation, early embryo development and embryonic genome activation (EGA). Color intensity of oocytes and embryos refers to lipid density. Mean size of oocytes at maturation are presented in proportion (mice ~80 μm). Average time periods of maturation and embryo development after onset of fertilization are illustrated by block arrows: oocyte maturation in hours (green arrows), transition from zygote to two-cells stage in hours (light purple arrows), transition of two-cells to blastocyst stage in days (purple arrows), and time to hatched blastocysts in days (dark purple arrows). Data were collected from in vivo and in vitro studies [34, 54–72].
Toxic compounds tested in vitro using bovine and porcine models
|
| Species | Exposure |
| Oocytes | Embryos | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bovine | Porcine | IVM | IVF | IVC | Viability | Expansion | Viability | MII | Fertilization/Activation | 2-4 cells | Blast | N nuclei | Ploidy | |
| Anabasine [ | 86 | 86 | 86 | |||||||||||
| Atrazine [ | 17,87 | 88 | 17,87,88 | 87 | 17,88 | 17, 88 | 87 | 87 | ||||||
| Benzo(a)pyrene [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| Benzyl butyl phthalate [ | 89 | 89 | 89 | 89 | ||||||||||
| Cadmium [ | 15,17 | 86 | 15,17,86 | 15 | 15,17 | 86 | 15,17 | 15 | ||||||
| Carbedazim [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| 4-Chloro-3-methyl phenol [ | 89 | 89 | 89 | 89 | ||||||||||
| Cotinine [ | 17 | 86 | 17,86 | 17 | 86 | 17 | ||||||||
| Cycloheximide [ | 15,17 | 15,17 | 15 | 15,17 | 15,17 | 15 | ||||||||
| DEHP [ | 90 | 89 | 89,90 | 89 | 89,90 | 90 | 90 | |||||||
| Diazinon [ | 88,91 | 88,91 | 91 | 91 | 88 | 91 | 88 | 91 | 91 | 91 | ||||
| DDT [ | 92 | 92 | 92 | 92 | 92 | 92 | 92 | |||||||
| Fenoxaprop-ethyl [ | 88 | 88 | 88 | 88 | ||||||||||
| Hexachlorocyclohexane [ | 92 | 92 | 92 | 92 | 92 | 92 | 92 | |||||||
| Lindane [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| Malathion [ | 88,91 | 88,91 | 91 | 91 | 88 | 91 | 88 | 91 | 91 | 91 | ||||
| Methoxychlor [ | 92 | 92 | 92 | 92 | 92 | 92 | 92 | |||||||
| MEHP [ | 17,90,93 | 17,90,93 | 17 | 93 | 17,90,93 | 90 | 90 | |||||||
| Nanoparticles Au-Ag [ | 94 | 94 | 94 | 94 | ||||||||||
| Nicotine [ | 17,95,96 | 86 | 17,86,95,96 | 95 | 95 | 17 | 86,95 | 17,95,96 | 95 | 95,96 | 95,96 | 96 | 96 | |
| PCB mixtures [ | 97-99 | 19,100-102 | 19,97-101 | 101 | 102 | 19,99,100 | 19,100 | 19 | 19,97-100 | 19,97,98, 100,101 | 19,97, 98,101 | 19,97,98, 100-102 | 98,101, 102 | |
| 4- | 103 | 103 | 103 | 103 | 103 | 103 | 103 | |||||||
|
| ||||||||||||||
| Bisphenol A [ | 89 | 89 | 89 | 89 | ||||||||||
| α-Chaconine [ | 104 | 104 | 104 | 104 | 104 | 104 | ||||||||
| Daidzein [ | 105 | 105 | 105 | 105 | 105 | 105 | 105 | |||||||
| Deoxynivalenol [ | 106-108 | 106-108 | 106 | 108 | 108 | 106-108 | 108 | 107,108 | 107,108 | 107,108 | 107,108 | |||
| Flavanones [ | 109 | 109 | 109 | 109 | 109 | 109 | 109 | |||||||
| Genistein [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| α-Solanine [ | 104 | 104 | 104 | 104 | 104 | 104 | ||||||||
| Solanidine-N-oxide [ | 104 | 104 | 104 | 104 | 104 | 104 | ||||||||
| Zearelanone [ | 110,111 | 107 | 107,110,111 | 107,110, 111 | 107,110 | 107,110 | 107 | 107 | ||||||
| α-zearalenol [ | 106,107, 112 | 106,107 | 106 | 106, 107 | 107,112 | 107,112 | 107,112 | 107 | ||||||
| β-zearalenol [ | 106,107 | 106,107 | 107 | 107 | 107 | 107 | ||||||||
|
| ||||||||||||||
| Busulfan [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| Diethylstilbestro l [ | 15,17 | 15,17 | 15 | 15,17 | 15,17 | 15 | ||||||||
| 17β-Estradiol [ | 17,103 | 17,103 | 17 | 17,103 | 103 | 103 | 103 | 103 | ||||||
| Ionomycin [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| Ketoconazole [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| Methyl acetoacetate [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| Mifepristone [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| Nocodazole [ | 15,17 | 15,17 | 15 | 15,17 | 15,17 | 15 | ||||||||
| Okadaic acid [ | 95 | 95 | 95 | 95 | ||||||||||
| Piperazine [ | 17 | 17 | 17 | 17 | ||||||||||
| Swainsonine [ | 113 | 113 | 113 | 113 | 113 | 113 | 113 | |||||||
| Taxol [ | 95 | 95 | 95 | 95 | ||||||||||
|
| ||||||||||||||
| Butylparaben [ | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
| 9-cis-Retinoic acid [ | 114 | 114 | 114 | 114 | ||||||||||
| Retinoic acid [ | 17 | 17 | 17 | 17 | ||||||||||
|
| ||||||||||||||
| Acrylamide [ | 17 | 17 | 17 | 17 | ||||||||||
DDT: Dichlorodiphenyltrichloroethane; DEHP: Di-(2-ethylhexyl) phthalate; MEHP: Mono-(2-ethylhexyl) phthalate; PCB: polychlorinated biphenyl.